A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.

Ann Med · 2026 · PMC12973816 · PMID 41797694

Europe PMC DOI

hedged sentence

0.0920

closest p · 1.8× alpha

0.0920

boldest claim

The sentences

showed a trendp = 0.092so close (0.05 < p ≤ 0.1)

Additionally, patients receiving BTKi-based therapy at any point showed a trend toward improved survival ( p = 0.092).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.